Дарья Варламова - С ума сойти! Путеводитель по психическим расстройствам для жителя большого города
- Название:С ума сойти! Путеводитель по психическим расстройствам для жителя большого города
- Автор:
- Жанр:
- Издательство:Литагент Альпина
- Год:2016
- ISBN:978-5-9614-4294-6
- Рейтинг:
- Избранное:Добавить в избранное
-
Ваша оценка:
Дарья Варламова - С ума сойти! Путеводитель по психическим расстройствам для жителя большого города краткое содержание
С ума сойти! Путеводитель по психическим расстройствам для жителя большого города - читать онлайн бесплатно ознакомительный отрывок
Шрифт:
Интервал:
Закладка:
К сожалению, качество обслуживания в психиатрических диспансерах и лечебницах все еще оставляет желать лучшего во всем мире, а если говорить о России, то, например, исследование 2013 г., проведенное в 57 регионах страны, показало, что 42 % зданий психиатрических стационаров требуют капитального ремонта {60} 60 Мартынихин И. О состоянии стационарных психиатрических учреждений РФ, Российское общество психиатров (6 декабря 2013 год, 09:35). http://psychiatr.ru/news/192
. Большинство из них было построено давно, и жизненное пространство пациентов у нас до сих пор организуется по канонам советской психиатрии, а из-за недостаточного финансирования палаты обставлены более чем скудно. Переполненность стационаров приводит к тому, что каждому отдельному больному уделяется мало внимания, а ввиду непрозрачности системы и слабости общественного контроля пациентам сложно бороться за свои права.
Конец ознакомительного фрагмента.
Текст предоставлен ООО «ЛитРес».
Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.
Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.
Комментарии
1
Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/
2
Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM – IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005 Jun; 62(6): 617–27.
3
Lenzenweger MF, Lane MC, Loranger AW, Kessler RC (2007). DSM – IV personality disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 62(6), 553–564.
4
Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto mental and addictive disorders service system. Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry. 1993 Feb; 50(2): 85–94.
5
Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15–4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/
6
http://ria.ru/society/20141010/1027775155.html
7
Kessler RC, Angermeyer M, Anthony Jc, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 2007; 6(3): 168–176.
8
http://gutta-honey.livejournal.com/113296.html
9
Marazziti D, Akiskal HS, Rossi A, Cassano GB. Alteration of the platelet serotonin transporter in romantic love. Psychol Med. 1999 May; 29(3): 741–5.
10
Bentall RP. A proposal to classify happiness as a psychiatric disorder. Journal of Medical Ethics. 1992; 18(2): 94–98.
11
https://www.youtube.com/watch?v=G_Qwp2GdB1M
12
Dima D, Roiser JP, Dietrich DE, Bonnemann C, Lanfermann H, Emrich HM, Dillo W. Understanding why patients with schizophrenia do not perceive the hollow-mask illusion using dynamic causal modelling. Neuroimage. 2009 Jul 15; 46(4): 1180–6. doi: 10.1016/j.neuroimage.2009.03.033.Epub 2009 Mar 24.
13
Rosenhan DL. On being sane in insane places. Science. 1973 Jan 19; 179(4070): 250–8.
14
Progler Y. Mental illness and social stigma: notes on "How Mad Are You?" Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2009; 14(5): 331–334.
15
Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 2009. Se; 117(1–2): 1–17.
16
Contribution of depression to cognitive impairment and dementia in older adults. Neurologist. 2007 May; 13(3): 105–17.
17
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing, p. 20. ISBN978–0–89042–555–8.
18
Dalgleish T. The emotional brain. Nat Rev Neurosci. 2004 Jul; 5(7): 583–9. Review.
19
Mega MS, Cummings JL, Salloway S, Malloy P. The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci. 1997 Summer; 9(3): 315–30. Review.
20
Robert Sapolsky (2005). "Biology and Human Behavior: The Neurological Origins of Individuality, 2nd edition". The Teaching Company, p. 13 & 14 of Guide Book.
21
Nichols DE. Hallucinogens. Pharmacol Ther. 2004 Feb; 101(2): 131–81. Review.
22
Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol. 2003 Jun; 63(6): 1223–9.
23
Kennett GA, Ainsworth K, Trail B, Blackburn TP. BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology. 1997 Feb; 36(2): 233–9.
24
Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation. 2000 Dec 5; 102(23): 2836–41.
25
de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004 Apr; 26(2): 137–44. Review.
26
Hofmann A. (1983). LSD, my problem child: Reflections on sacred drugs, mysticism, and science. Los Angeles: J. P. Tarcher. P. 21.
27
Andersson A, Wiréhn A-B, Ölvander C, Ekman DS, Bendtsen P. Alcohol use among university students in Sweden measured by an electronic screening instrument. BMC Public Health. 2009;9:229. doi: 10.1186/1471-2458-9-229.
28
Kellett J, Kokkinidis L. Extinction deficit and fear reinstatement after electrical stimulation of the amygdala: implications for kindling-associated fear and anxiety. Neuroscience. 2004; 127(2): 277–87.
29
Ghaemi SN. The rise and fall of the biopsychosocial model. Br J Psychiatry. 2009 Jul; 195(1): 3–4. doi: 10.1192/bjp.bp.109.063859.
30
Haygarth, John. (1800). Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the Literary and Philosophical Society of Bath. By John Haygarth, M.D. … Bath: printed by R. Cruttwell; and sold by Cadell and Davies, London.
31
Beecher HK. The powerful placebo. J Am Med Assoc. 1955; 159(17): 1602–6.
32
Howick J, Friedemann C, Tsakok M, et al. Are treatments more effective than placebos? A systematic review and meta-analysis. PLoS ONE. 2013; 8(5): e62599.
33
Linde K, Fässler M, Meissner K. Placebo interventions, placebo effects and clinical practice. Philos Trans R Soc Lond, B, Biol Sci. 2011; 366(1572): 1905–12.
34
Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry. 2008; 65(2): 220–31.
35
Oken BS. Placebo effects: clinical aspects and neurobiology. Brain. 2008; 131(Pt 11): 2812–23.
36
Matre D, Casey KL, Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci. 2006; 26(2): 559–63.
37
Qiu YH, Wu XY, Xu H, Sackett D. Neuroimaging study of placebo analgesia in humans. Neurosci Bull. 2009; 25(5): 277–82.
38
Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009; 1156: 198–210.
39
Lidstone SC, Stoessl AJ. Understanding the placebo effect: contributions from neuroimaging. Mol Imaging Biol. 2007; 9(4): 176–85.
40
Misra S. Randomized double blind placebo control studies, the "Gold Standard" in intervention based studies. Indian Journal of Sexually Transmitted Diseases. 2012; 33(2): 131–134.
41
Levine R. A Real Mental Ward Becomes A Movie 'Cuckoo's Nest'. The New York Times. April 13, 1975. http://www.nytimes.com/packages/html/movies/bestpictures/cuckoo-ar1.html. Accessed Feb 25, 2016.
42
Tooth GC, and Newton, MP: Leukotomy in England and Wales 1942–1954. London, Her Majesty's Stationary Office, 1961.
43
Jansson B. Controversial Psychosurgery Resulted in a Nobel Prize. Nobel Media AB2014. http://www.nobelprize.org/nobel_prizes/medicine/laureates/1949/moniz-article.html. Accessed Feb 25, 2016.
44
Soares MS, Paiva WS, Guertzenstein EZ, et al. Psychosurgery for schizophrenia: history and perspectives. Neuropsychiatric Disease and Treatment. 2013; 9: 509–515.
45
http://www.youtube.com/watch?v=yQa_sg4zN88
46
Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003; 361(9360): 799–808.
Шрифт:
Интервал:
Закладка:
